First Light Asset Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
First Light Asset Management, LLC disclosed 38 US equity positions worth $1.2bn in its Q3 2024 13F filing. The largest position was CNTA at 7.9% of the reported book, followed by FNAUSD and EVH.
What did First Light Asset Management, LLC own in Q3 2024? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | CNTA CENTESSA PHARMACEUTICALS LIMITED | 7.9% | $95.0m | 5,940,132 | – | ||
| 2 | FNAUSD PARAGON 28 INC | 5.6% | $67.8m | 10,154,643 | – | ||
| 3 | EVH EVOLENT HEALTH INC | Healthcare | 5.4% | $65.0m | 2,298,261 | – | |
| 4 | AXGN AXOGEN INC | Healthcare | 4.8% | $57.3m | 4,090,296 | – | |
| 5 | ATRC ATRICURE INC | Healthcare | 4.4% | $52.3m | 1,865,536 | – | |
| 6 | INSM INSMED INC | Healthcare | 4.2% | $50.3m | 688,910 | – | |
| 7 | CRNXGBP CRINETICS PHARMACEUTICALS INC | 4.0% | $48.2m | 943,611 | – | ||
| 8 | XENE XENON PHARMACEUTICALS | Healthcare | 3.9% | $46.5m | 1,181,662 | – | |
| 9 | NEO NEOGENOMICS INC | Healthcare | 3.8% | $45.4m | 3,076,555 | – | |
| 10 | DYN DYNE THERAPEUTICS INC | Healthcare | 3.8% | $45.2m | 1,257,285 | – | |
| 11 | TNDM TANDEM DIABETES CARE INC | Healthcare | 3.6% | $43.5m | 1,025,307 | – | |
| 12 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 3.5% | $41.9m | 755,102 | – | |
| 13 | PFMTUSD PERFORMANT FINANCIAL CORPORATION | 3.5% | $41.9m | 11,210,400 | – | ||
| 14 | TMDX TRANSMEDICS GROUP INC | Healthcare | 3.5% | $41.7m | 265,734 | – | |
| 15 | OSCR OSCAR HEALTH INC CLASS A | Healthcare | 3.1% | $37.5m | 1,765,892 | – | |
| 16 | PODD INSULET CORP | Healthcare | 3.1% | $37.0m | 159,082 | – | |
| 17 | HCAT HEALTH CATALYST INC | Healthcare | 2.9% | $35.0m | 4,296,490 | – | |
| 18 | ANAB ANAPTYS BIO INC | Healthcare | 2.6% | $31.8m | 948,131 | – | |
| 19 | PPHMEUR AVID BIOSERVICES INC | 2.6% | $31.5m | 2,771,853 | – | ||
| 20 | VERA VERA THERAPEUTICS INC | Healthcare | 2.6% | $31.2m | 705,234 | – | |
| 21 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 2.4% | $28.9m | 2,575,546 | – | |
| 22 | RGEN REPLIGEN CORP | Healthcare | 2.1% | $24.7m | 165,873 | – | |
| 23 | NTRA NATERA INC | Healthcare | 2.0% | $23.5m | 184,939 | – | |
| 24 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.8% | $22.2m | 506,222 | – | |
| 25 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 1.8% | $21.9m | 967,006 | – | |
| 26 | SIBN SI-BONE INC | Healthcare | 1.8% | $21.3m | 1,526,215 | – | |
| 27 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 1.6% | $19.2m | 406,348 | – | |
| 28 | KRMD KORU MEDICAL SYSTEMS INC | 1.3% | $15.3m | 5,598,925 | – | ||
| 29 | GH GUARDANT HEALTH | Healthcare | 1.2% | $14.9m | 648,993 | – | |
| 30 | OPRX OPTIMIZERX CORP | Healthcare | 1.2% | $14.0m | 1,811,611 | – | |
| 31 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.9% | $10.9m | 1,542,406 | – | |
| 32 | AVTR AVANTOR INC | Healthcare | 0.8% | $9.3m | 359,150 | – | |
| 33 | MOH MOLINA HEALTHCARE INC | Healthcare | 0.8% | $9.1m | 26,528 | – | |
| 34 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.6% | $7.7m | 51,723 | – | |
| 35 | NARIUSD INARI MEDICAL INC. | 0.6% | $7.2m | 174,590 | – | ||
| 36 | EXK EXACT SCIENCES CORP | Basic Materials | 0.4% | $4.7m | 69,447 | – | |
| 37 | ATEC ALPHATEC HOLDINGS INC | Healthcare | 0.1% | $767.3k | 138,006 | – | |
| 38 | SONX SONENDO INC | 0.0% | $253.7k | 5,886,207 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.